The influence of natural organic matter and cations on the rejection of endocrine disrupting and pharmaceutically active compounds by nanofiltration.
暂无分享,去创建一个
[1] Adriano Joss,et al. Removal of estrogens in municipal wastewater treatment under aerobic and anaerobic conditions: consequences for plant optimization. , 2004, Environmental science & technology.
[2] T. Ternes. Occurrence of drugs in German sewage treatment plants and rivers 1 Dedicated to Professor Dr. Klaus , 1998 .
[3] T. Schettler,et al. Environment and health: 6. Endocrine disruption and potential human health implications. , 2000, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[4] M. Elimelech,et al. Nanofiltration of Hormone Mimicking Trace Organic Contaminants , 2005 .
[5] A. E. Greenberg,et al. Standard methods for the examination of water and wastewater : supplement to the sixteenth edition , 1988 .
[6] Christopher Bellona,et al. Effect of membrane fouling on transport of organic contaminants in NF/RO membrane applications , 2006 .
[7] Shane A. Snyder,et al. Nanofiltration and ultrafiltration of endocrine disrupting compounds, pharmaceuticals and personal care products , 2006 .
[8] Jaeweon Cho,et al. Membrane filtration of natural organic matter: factors and mechanisms affecting rejection and flux decline with charged ultrafiltration (UF) membrane , 2000 .
[9] Christopher Bellona,et al. Factors affecting the rejection of organic solutes during NF/RO treatment--a literature review. , 2004, Water research.
[10] Charles D. Norris,et al. Influences of molecular weight, molecular size, flux, and recovery for aromatic pesticide removal by nanofiltration membranes , 2004 .
[11] Taro Urase,et al. Change in membrane performance due to organic fouling in nanofiltration (NF)/reverse osmosis (RO) applications , 2007 .
[12] Christopher Bellona,et al. Rejection of wastewater‐derived micropollutants in high‐pressure membrane applications leading to indirect potable reuse , 2005 .
[13] Stephen Safe,et al. Endocrine disruptors and human health: is there a problem. , 2004, Toxicology.
[14] Peter Seto,et al. Distribution of estrogens, 17β-estradiol and estrone, in Canadian municipal wastewater treatment plants , 2005 .
[15] Menachem Elimelech,et al. Pharmaceutical retention mechanisms by nanofiltration membranes. , 2005, Environmental science & technology.
[16] C. Vandecasteele,et al. Removal of pesticides by nanofiltration: effect of the water matrix , 2004 .
[17] T. Matsuura,et al. MEMBRANE CHARACTERIZATION BY SOLUTE TRANSPORT AND ATOMIC FORCE MICROSCOPY , 1998 .
[18] S. Safe. Clinical correlates of environmental endocrine disruptors , 2005, Trends in Endocrinology & Metabolism.
[19] Erin R Bennett,et al. Ozone treatment and the depletion of detectable pharmaceuticals and atrazine herbicide in drinking water sourced from the upper Detroit River, Ontario, Canada. , 2006, Water research.
[20] Sigrid Peldszus,et al. Optimizing gas chromatographic-mass spectrometric analysis of selected pharmaceuticals and endocrine-disrupting substances in water using factorial experimental design. , 2007, Journal of chromatography. A.
[21] Andrea I. Schäfer,et al. Particle interactions and removal of trace contaminants from water and wastewaters , 2002 .
[22] Robert C. Andrews,et al. Membrane adsorption of endocrine disrupting compounds and pharmaceutically active compounds , 2007 .
[23] B. Van der Bruggen,et al. Influence of molecular size, polarity and charge on the retention of organic molecules by nanofiltration , 1999 .
[24] Long D. Nghiem,et al. Estrogenic hormone removal from wastewater using NF/RO membranes , 2004 .
[25] M. Wiesner,et al. Effects of natural organic matter and the raw water matrix on the rejection of atrazine by pressure-driven membranes , 1998 .
[26] Jing-den Chen,et al. Edge profiles and dynamic contact angles of a spreading drop , 1992 .
[27] Shane A. Snyder,et al. Role of membranes and activated carbon in the removal of endocrine disruptors and pharmaceuticals , 2007 .
[28] Joon-Wun Kang,et al. Effect of Ozone and GAC Process for the Treatment of Micropollutants and DBPs Control in Drinking Water: Pilot Scale Evaluation , 2005 .
[29] D. Bagley,et al. The rejection of endocrine disrupting and pharmaceutically active compounds by NF and RO membranes as a function of compound and water matrix properties , 2008 .
[30] Alden K Henderson,et al. Persistence of pharmaceutical compounds and other organic wastewater contaminants in a conventional drinking-water-treatment plant. , 2004, The Science of the total environment.
[31] Samer Adham,et al. The state of full‐scale RO/NF desalination —results from a worldwide survey , 2007 .
[32] W. P. Ball,et al. NANOFILTRATION OF NATURAL ORGANIC MATTER: pH AND IONIC STRENGTH EFFECTS , 1997 .
[33] Shane Snyder,et al. Fate of endocrine-disruptor, pharmaceutical, and personal care product chemicals during simulated drinking water treatment processes. , 2005, Environmental science & technology.
[34] Menachem Elimelech,et al. Chemical and physical aspects of natural organic matter (NOM) fouling of nanofiltration membranes , 1997 .
[35] L. Nghiem,et al. Effects of membrane fouling on the nanofiltration of pharmaceutically active compounds (PhACs): Mechanisms and role of membrane pore size , 2007 .
[36] Francis A. DiGiano,et al. Alternative tests for evaluating NF fouling , 2000 .
[37] M. Kumke,et al. Sorption of phenols to dissolved organic matter investigated by solid phase microextraction. , 2000, The Science of the total environment.
[38] Menachem Elimelech,et al. Effect of solution chemistry on the surface charge of polymeric reverse osmosis and nanofiltration membranes , 1996 .
[39] M. Clark,et al. Adsorption of aquatic humic substances on hydrophobic ultrafiltration membranes , 1994 .
[40] P. Anderson,et al. Human pharmaceuticals in US surface waters: a human health risk assessment. , 2005, Regulatory toxicology and pharmacology : RTP.
[41] A. Karabelas,et al. A study of selected herbicides retention by nanofiltration membranes—The role of organic fouling , 2006 .
[42] J. Sumpter,et al. Removal of endocrine-disrupting chemicals in activated sludge treatment works. , 2001, Environmental science & technology.